{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:50:39Z","timestamp":1792792239057,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T00:00:00Z","timestamp":1655078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T00:00:00Z","timestamp":1655078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Since the publication of the Z0011 trial, practice-changing clinical guidelines for breast surgery have been developed. Although recent studies confirmed the feasibility of the Z0011 strategy in Asian populations, there has been no study on the trends of axillary surgery in Asian cohort. This study aimed to investigate the time trend of axillary surgery for breast cancer from a Korean Breast Cancer Registry to understand the impact of the Z0011 trial in Asian patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We collected prospectively constructed data from the nationwide Korean Breast Cancer Registry (KBCR). We identified patients who underwent sentinel node biopsy followed by breast-conserving surgery from 2011 to 2018 and were found to have pathological stage T1-2N1-3M0 disease. Regression analyses were performed to compare the downward trend of axillary lymph node dissection (ALND) in Korean cohort with that previously reported in a Dutch cohort.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>From KBCR data, 7478 patients met the inclusion criteria. The proportion of ALND significantly decreased from 2011 (76.6%) to 2018 (47.5%). Multivariate analysis revealed that earlier years at diagnosis, larger tumor size, and lymphatic invasion were associated with a higher odds ratio of performing ALND. Compared to the Dutch cohort, the downward trend of ALND in Korea was significantly more gradual (annual percent change: 37.2 vs. 5.8%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study demonstrated a downward trend of ALND in Korean patients with breast cancer. However, the rate of decrease was significantly slower than that in the Dutch cohort.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12957-022-02673-4","type":"journal-article","created":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T17:03:52Z","timestamp":1655139832000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Impact of the ACOSOG Z0011 trial on surgical practice in Asian patients: trends in axillary surgery for breast cancer from a Korean Breast Cancer Registry analysis"],"prefix":"10.1186","volume":"20","author":[{"given":"Chihwan","family":"Cha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Yong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jai Min","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Ho","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seokwon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-jin","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nayeon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanpyo","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung Suk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5086-3718","authenticated-orcid":false,"given":"Min Sung","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Korean Breast Cancer Society","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,13]]},"reference":[{"issue":"3","key":"2673_CR1","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1245\/s10434-008-0195-5","volume":"16","author":"J Rescigno","year":"2009","unstructured":"Rescigno J, Zampell JC, Axelrod D. Patterns of axillary surgical care for breast cancer in the era of sentinel lymph node biopsy. Ann Surg Oncol. 2009;16(3):687\u201396.","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"2673_CR2","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1097\/SLA.0b013e3181c0e92a","volume":"251","author":"U Veronesi","year":"2010","unstructured":"Veronesi U, Viale G, Paganelli G, Zurrida S, Luini A, Galimberti V, et al. Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study. Ann Surg. 2010;251(4):595\u2013600.","journal-title":"Ann Surg"},{"issue":"4","key":"2673_CR3","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S1470-2045(13)70035-4","volume":"14","author":"V Galimberti","year":"2013","unstructured":"Galimberti V, Cole BF, Zurrida S, Viale G, Luini A, Veronesi P, et al. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23\u201301): a phase 3 randomised controlled trial. Lancet Oncol. 2013;14(4):297\u2013305.","journal-title":"Lancet Oncol"},{"issue":"12","key":"2673_CR4","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","volume":"15","author":"M Donker","year":"2014","unstructured":"Donker M, van Tienhoven G, Straver ME, Meijnen P, van de Velde CJ, Mansel RE, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981\u201322023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol. 2014;15(12):1303\u201310.","journal-title":"Lancet Oncol"},{"issue":"6","key":"2673_CR5","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/cncr.28499","volume":"120","author":"R Agresti","year":"2014","unstructured":"Agresti R, Martelli G, Sandri M, Tagliabue E, Carcangiu ML, Maugeri I, et al. Axillary lymph node dissection versus no dissection in patients with T1N0 breast cancer: a randomized clinical trial (INT09\/98). Cancer. 2014;120(6):885\u201393.","journal-title":"Cancer"},{"issue":"6","key":"2673_CR6","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1001\/jama.2011.90","volume":"305","author":"AE Giuliano","year":"2011","unstructured":"Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305(6):569\u201375.","journal-title":"JAMA"},{"issue":"3","key":"2673_CR7","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/SLA.0000000000001863","volume":"264","author":"AE Giuliano","year":"2016","unstructured":"Giuliano AE, Ballman K, McCall L, Beitsch P, Whitworth PW, Blumencranz P, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: long-term follow-up from the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 Randomized Trial. Ann Surg. 2016;264(3):413\u201320.","journal-title":"Ann Surg"},{"key":"2673_CR8","unstructured":"National comprehensive cancer Network clinical practice guidelines in Oncology: breast cancer (ver 1.2021) [Available from: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast_blocks.pdf."},{"issue":"5","key":"2673_CR9","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1200\/JCO.2016.71.0947","volume":"35","author":"GH Lyman","year":"2017","unstructured":"Lyman GH, Somerfield MR, Bosserman LD, Perkins CL, Weaver DL, Giuliano AE. Sentinel lymph node biopsy for patients with early-stage breast cancer: American society of clinical oncology clinical practice guideline update. J Clin Oncol. 2017;35(5):561\u20134.","journal-title":"J Clin Oncol"},{"issue":"6","key":"2673_CR10","doi-asserted-by":"publisher","first-page":"712","DOI":"10.3109\/0284186X.2015.1136751","volume":"55","author":"A Gondos","year":"2016","unstructured":"Gondos A, Jansen L, Heil J, Schneeweiss A, Voogd AC, Frisell J, et al. Time trends in axilla management among early breast cancer patients: persisting major variation in clinical practice across European centers. Acta Oncol. 2016;55(6):712\u20139.","journal-title":"Acta Oncol"},{"key":"2673_CR11","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.breast.2019.03.002","volume":"45","author":"CA Garcia-Etienne","year":"2019","unstructured":"Garcia-Etienne CA, Mansel RE, Tomatis M, Heil J, Biganzoli L, Ferrari A, et al. Trends in axillary lymph node dissection for early-stage breast cancer in Europe: impact of evidence on practice. Breast. 2019;45:89\u201396.","journal-title":"Breast"},{"issue":"9","key":"2673_CR12","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1245\/s10434-011-1857-2","volume":"18","author":"M Morrow","year":"2011","unstructured":"Morrow M, Giuliano AE. To cut is to cure: can we really apply Z11 in practice? Ann Surg Oncol. 2011;18(9):2413\u20135.","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"2673_CR13","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s10585-012-9515-z","volume":"29","author":"AE Giuliano","year":"2012","unstructured":"Giuliano AE, Morrow M, Duggal S, Julian TB. Should ACOSOG Z0011 change practice with respect to axillary lymph node dissection for a positive sentinel lymph node biopsy in breast cancer? Clin Exp Metastasis. 2012;29(7):687\u201392.","journal-title":"Clin Exp Metastasis"},{"issue":"8","key":"2673_CR14","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.ejso.2012.04.018","volume":"38","author":"U G\u00fcth","year":"2012","unstructured":"G\u00fcth U, Myrick ME, Viehl CT, Schmid SM, Obermann EC, Weber WP. The post ACOSOG Z0011 era: does our new understanding of breast cancer really change clinical practice? Eur J Surg Oncol. 2012;38(8):645\u201350.","journal-title":"Eur J Surg Oncol"},{"issue":"34","key":"2673_CR15","doi-asserted-by":"publisher","first-page":"3902","DOI":"10.1200\/JCO.2014.57.3717","volume":"32","author":"A Goyal","year":"2014","unstructured":"Goyal A, Dodwell D, Reed MW, Coleman RE. Axillary treatment in women with one or two sentinel nodes with macrometastases: more evidence is needed to inform practice. J Clin Oncol. 2014;32(34):3902.","journal-title":"J Clin Oncol"},{"issue":"3","key":"2673_CR16","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.ejca.2012.09.014","volume":"49","author":"N Bhoo-Pathy","year":"2013","unstructured":"Bhoo-Pathy N, Yip CH, Hartman M, Uiterwaal CS, Devi BC, Peeters PH, et al. Breast cancer research in Asia: adopt or adapt Western knowledge? Eur J Cancer. 2013;49(3):703\u20139.","journal-title":"Eur J Cancer"},{"issue":"5","key":"2673_CR17","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3322\/caac.21565","volume":"69","author":"KD Miller","year":"2019","unstructured":"Miller KD, Nogueira L, Mariotto AB, Rowland JH, Yabroff KR, Alfano CM, et al. Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin. 2019;69(5):363\u201385.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"2673_CR18","doi-asserted-by":"publisher","first-page":"335","DOI":"10.4143\/crt.2020.206","volume":"52","author":"S Hong","year":"2020","unstructured":"Hong S, Won YJ, Park YR, Jung KW, Kong HJ, Lee ES. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2017. Cancer Res Treat. 2020;52(2):335\u201350.","journal-title":"Cancer Res Treat"},{"key":"2673_CR19","doi-asserted-by":"publisher","first-page":"15241","DOI":"10.1038\/srep15241","volume":"5","author":"M Liu","year":"2015","unstructured":"Liu M, Wang S, Cui S, Duan X, Fan Z, Yu Z. The feasibility of the ACOSOG Z0011 criteria to Chinese Breast Cancer Patients: a multicenter study. Sci Rep. 2015;5:15241.","journal-title":"Sci Rep"},{"issue":"1","key":"2673_CR20","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s10549-019-05157-4","volume":"175","author":"J Jung","year":"2019","unstructured":"Jung J, Han W, Lee ES, Jung SY, Han JH, Noh DY, et al. Retrospectively validating the results of the ACOSOG Z0011 trial in a large Asian Z0011-eligible cohort. Breast Cancer Res Treat. 2019;175(1):203\u201315.","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"2673_CR21","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1097\/SLA.0000000000002440","volume":"268","author":"IGM Poodt","year":"2018","unstructured":"Poodt IGM, Spronk PER, Vugts G, van Dalen T, Peeters M, Rots ML, et al. Trends on axillary surgery in nondistant metastatic breast cancer patients treated between 2011 and 2015: a Dutch population-based study in the ACOSOG-Z0011 and AMAROS Era. Ann Surg. 2018;268(6):1084\u201390.","journal-title":"Ann Surg"},{"issue":"5","key":"2673_CR22","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1007\/s10147-018-1297-0","volume":"23","author":"N Kittaka","year":"2018","unstructured":"Kittaka N, Tokui R, Ota C, Hashimoto Y, Motomura K, Ishitobi M, et al. A prospective feasibility study applying the ACOSOG Z0011 criteria to Japanese patients with early breast cancer undergoing breast-conserving surgery. Int J Clin Oncol. 2018;23(5):860\u20136.","journal-title":"Int J Clin Oncol"},{"issue":"1","key":"2673_CR23","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1503\/cjs.036011","volume":"55","author":"S Latosinsky","year":"2012","unstructured":"Latosinsky S, Berrang TS, Cutter CS, George R, Olivotto I, Julian TB, et al. CAGS and ACS evidence based reviews in surgery. 40. Axillary dissection versus no axillary dissection in women with invasive breast cancer and sentinel node metastasis. Can J Surg. 2012;55(1):66\u20139.","journal-title":"Can J Surg"},{"issue":"34","key":"2673_CR24","doi-asserted-by":"publisher","first-page":"3901","DOI":"10.1200\/JCO.2014.57.1190","volume":"32","author":"IA Voutsadakis","year":"2014","unstructured":"Voutsadakis IA, Spadafora S. Recommendation for omitting axillary lymph node dissection should be individualized in patients with breast cancer with one or two positive sentinel lymph nodes. J Clin Oncol. 2014;32(34):3901\u20132.","journal-title":"J Clin Oncol"},{"issue":"1","key":"2673_CR25","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12957-021-02242-1","volume":"19","author":"Y Peng","year":"2021","unstructured":"Peng Y, Liu M, Li X, Tong F, Cao Y, Lio P, et al. Application of the ACOSOG Z0011 criteria to Chinese patients with breast cancer: a prospective study. World J Surg Onc. 2021;19(1):128.","journal-title":"World J Surg Onc"},{"issue":"11","key":"2673_CR26","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1001\/jamaoncol.2018.1908","volume":"4","author":"M Morrow","year":"2018","unstructured":"Morrow M, Jagsi R, McLeod MC, Shumway D, Katz SJ. Surgeon attitudes toward the omission of axillary dissection in early breast cancer. JAMA Oncol. 2018;4(11):1511\u20136.","journal-title":"JAMA Oncol"},{"issue":"21","key":"2673_CR27","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1001\/jama.295.21.2492","volume":"295","author":"LA Carey","year":"2006","unstructured":"Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, et al. Race, breast cancer subtypes, and survival in the Carolina breast cancer study. JAMA. 2006;295(21):2492\u2013502.","journal-title":"JAMA"},{"issue":"1","key":"2673_CR28","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12957-021-02214-5","volume":"19","author":"Y Li","year":"2021","unstructured":"Li Y, Lu S, Zhang Y, Wang S, Liu H. Loco-regional recurrence trend and prognosis in young women with breast cancer according to molecular subtypes: analysis of 1099 cases. World J Surg Onc. 2021;19(1):113.","journal-title":"World J Surg Onc"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-022-02673-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-022-02673-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-022-02673-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T17:05:16Z","timestamp":1655139916000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-022-02673-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,13]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2673"],"URL":"https:\/\/doi.org\/10.1186\/s12957-022-02673-4","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,13]]},"assertion":[{"value":"4 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was approved by the appropriate ethics review board, and the requirement informed consent was waived due to the study\u2019s retrospective design.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and approved the final version of the manuscript being submitted and fulfill the COPE (Committee on Publication Ethics) requirements for authorship.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"198"}}